薬局の市場規模、シェア、成長分析：薬局別、提供製品別、在庫状況別、薬剤の種類別、薬剤分子の種類別、地域別 - 産業予測 2025～2032年

薬局市場規模は2023年に1兆5,000億米ドルと評価され、2024年の1兆5,800億米ドルから2032年には2兆4,500億米ドルに成長し、予測期間（2025年～2032年）のCAGRは5.6%で成長する見通しです。

薬局市場は、慢性疾患の増加、ヘルスケア需要の高まり、医薬品技術の進歩などを背景に急速に進化しています。主な成長要因としては、個別化医療のニーズの高まり、ジェネリック医薬品の普及、オンライン薬局の拡大などが挙げられます。しかし、この分野は厳しい規制、新薬開発のための高い研究開発費、価格圧力などの課題に直面しています。このようなハードルにもかかわらず、薬局市場は、デジタルヘルス・ソリューション、遠隔医療サービス、特に新興国地域における予防医療需要の高まりなどの機会に後押しされ、成長の態勢を整えています。全体として、このダイナミックな情勢は、競争の激しい薬局分野で成功するための革新と適応の必要性を強調しています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• ケーススタディ
• 技術分析

薬局市場規模：薬局別

• 市場概要
• 小売業薬局
• 電子薬局
• 病院薬局
• その他の薬局

薬局市場規模：提供製品別

• 市場概要
• 医薬品
• 医療機器
• その他の薬局製品

薬局市場規模：在庫状況別

• 市場概要
• 処方薬
• 市販薬

薬局市場規模：薬剤の種類別

• 市場概要
• ブランド薬/特許薬
• ジェネリック医薬品

薬局市場規模：薬剤分子の種類別

• 市場概要
• 小分子
• 生物学的製剤

薬局市場規模： e薬局プラットフォームの種類別

• 市場概要
• アプリベースのプラットフォーム
• ウェブベースのプラットフォーム

薬局市場規模：治療領域別

• 市場概要
• 腫瘍性疾患
• 心血管疾患
• 神経疾患
• 感染症
• 代謝障害
• 呼吸器疾患
• 皮膚疾患
• 遺伝性疾患
• 自己免疫疾患/炎症性疾患
• その他の障害

薬局市場規模

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022～2024年）

主要企業プロファイル

• CVS Health Corporation（USA）
• AmerisourceBergen Corporation（USA）
• McKesson Corporation（USA）
• Cardinal Health, Inc.（USA）
• Rite Aid Corporation（USA）
• OptumRx, Inc.（USA）
• Humana Inc.（USA）
• Groupe Pharmagest S.A.（France）
• MedImpact Healthcare Systems, Inc.（USA）
• AllianceRx Walgreens Prime（USA）
• Benzer Pharmacy（USA）
• Kroger Health（USA）
• HealthWarehouse.com, Inc.（USA）

結論と提言

Pharmacy Market size was valued at USD 1.5 trillion in 2023 and is poised to grow from USD 1.58 trillion in 2024 to USD 2.45 trillion by 2032, growing at a CAGR of 5.6% during the forecast period (2025-2032).

The pharmacy market is rapidly evolving, driven by an increase in chronic illnesses, heightened healthcare demands, and advancements in pharmaceutical technology. Key growth factors include the rising need for personalized medicine, the proliferation of generic drugs, and the expansion of online pharmacies. However, the sector faces challenges such as stringent regulations, high R&D costs for new drug development, and pricing pressures. Despite these hurdles, the pharmacy market is poised for growth, fueled by opportunities in digital health solutions, telehealth services, and the rising demand for preventive care, especially in developing regions. Overall, this dynamic landscape underscores the need for innovation and adaptation to thrive in the competitive pharmacy sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Pharmacy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Pharmacy Market Segments Analysis

Global Pharmacy Market is segmented by Pharmacy, Product Offered, Availability, Type of Drug, Type of Drug Molecule, Type of E-Pharmacy Platform, Therapeutic Area and region. Based on Pharmacy, the market is segmented into Retail Pharmacy, e-pharmacy, Hospital Pharmacy and Other Pharmacies. Based on Product Offered, the market is segmented into Drugs / Pharmaceuticals, Medical Devices and Other Pharmacy Products. Based on Availability, the market is segmented into Prescription Products and Over-the-counter Products. Based on Type of Drug, the market is segmented into Branded / Patented Drugs and Generic Drugs. Based on Type of Drug Molecule, the market is segmented into Small Molecules and Biologics. Based on Type of e-pharmacy Platform, the market is segmented into App-based Platforms and Web-based Platforms. Based on Therapeutic Area, the market is segmented into Oncological Disorders, Cardiovascular Disorders, Neurological Disorders, Infectious Diseases, Metabolic Disorders, Respiratory Disorders, Dermatological Disorders, Genetic Disorders, Autoimmune / Inflammatory Disorders and Other Disorders. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Pharmacy Market

Advancements in biotechnology are leading to an increased number of drug developments, particularly in the areas of biosimilars and biologics, which offer enhanced reliability and efficacy for various health conditions. Additionally, the rising significance of customized and personalized genetic information is influencing the demand for tailored medicines and products. These developments are driving significant growth within the pharmacy market, as healthcare providers and patients alike seek innovative solutions that cater to individual health needs, ultimately enhancing treatment outcomes and fostering a more personalized approach to medicine. Overall, these trends are transforming the landscape of the pharmacy sector.

Restraints in the Pharmacy Market

The pharmacy market faces significant constraints due to the high costs associated with developing and bringing new drugs to market, often amounting to millions or even billions of dollars. This financial burden tends to inhibit smaller companies from entering the market and effectively promoting their products. Additionally, a substantial number of drug candidates fail in clinical trials, resulting in considerable financial losses. These challenges collectively hinder the expansion and innovation within the pharmacy industry, as they disproportionately affect smaller players and deter investments needed for research and development. Consequently, the overall growth potential of the pharmacy market is restrained.

Market Trends of the Pharmacy Market

The pharmacy market is witnessing a significant trend towards personalized medicine, fueled by advancements in genomic testing and targeted therapies. This shift is particularly prominent in the management of chronic diseases and oncology, where individualized treatment plans can improve outcomes and enhance patient experiences. The rise of biosimilars and biologics further complements this trend by offering more effective and tailored treatment options for complex health conditions. As healthcare providers and patients increasingly prioritize customized therapies, the pharmacy sector must adapt to meet this growing demand, paving the way for innovative solutions and enhancing overall patient care in an evolving healthcare landscape.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Technology Analysis

Global Pharmacy Market Size by Pharmacy & CAGR (2025-2032)

• Market Overview
• Retail Pharmacy
• e-pharmacy
• Hospital Pharmacy
• Other Pharmacies

Global Pharmacy Market Size by Product Offered & CAGR (2025-2032)

• Market Overview
• Drugs / Pharmaceuticals
• Medical Devices
• Other Pharmacy Products

Global Pharmacy Market Size by Availability & CAGR (2025-2032)

• Market Overview
• Prescription Products
• Over-the-counter Products

Global Pharmacy Market Size by Type of Drug & CAGR (2025-2032)

• Market Overview
• Branded / Patented Drugs
• Generic Drugs

Global Pharmacy Market Size by Type of Drug Molecule & CAGR (2025-2032)

• Market Overview
• Small Molecules
• Biologics

Global Pharmacy Market Size by Type of e-pharmacy Platform & CAGR (2025-2032)

• Market Overview
• App-based Platforms
• Web-based Platforms

Global Pharmacy Market Size by Therapeutic Area & CAGR (2025-2032)

• Market Overview
• Oncological Disorders
• Cardiovascular Disorders
• Neurological Disorders
• Infectious Diseases
• Metabolic Disorders
• Respiratory Disorders
• Dermatological Disorders
• Genetic Disorders
• Autoimmune / Inflammatory Disorders
• Other Disorders

Global Pharmacy Market Size & CAGR (2025-2032)

• North America (Pharmacy, Product Offered, Availability, Type of Drug, Type of Drug Molecule, Type of e-pharmacy Platform, Therapeutic Area)
  • US
  • Canada
• Europe (Pharmacy, Product Offered, Availability, Type of Drug, Type of Drug Molecule, Type of e-pharmacy Platform, Therapeutic Area)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Pharmacy, Product Offered, Availability, Type of Drug, Type of Drug Molecule, Type of e-pharmacy Platform, Therapeutic Area)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Pharmacy, Product Offered, Availability, Type of Drug, Type of Drug Molecule, Type of e-pharmacy Platform, Therapeutic Area)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Pharmacy, Product Offered, Availability, Type of Drug, Type of Drug Molecule, Type of e-pharmacy Platform, Therapeutic Area)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• CVS Health Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AmerisourceBergen Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• McKesson Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rite Aid Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OptumRx, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Humana Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Groupe Pharmagest S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MedImpact Healthcare Systems, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AllianceRx Walgreens Prime (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Benzer Pharmacy (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kroger Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HealthWarehouse.com, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations